Abstract
AbstractMedical devices are an integral part of therapeutic management; despite their importance, they carry a significant risk of microbial infection. Bacterial attachment to a medical device is established by a single, multiplying organism, leading to subsequent biofilm formation. To date, no preventative measures have impacted the incidence of device-related infection. We report the bidirectional covalent coupling of an engineered cationic antimicrobial peptide (eCAP), WLBU2, to various biological surfaces is accomplished. These surfaces included (i) a carbohydrate-based gel matrix, (ii) a complex polymeric plastic bead, and (iii) a silica-calcium phosphate nanocomposite associated with bone reconstruction. WLBU2-conjugated surfaces are shown to retain potent antimicrobial activity related to bacterial surface adhesion. This study provides proof of principle that covalently coating laboratory and bone-regenerating materials with eCAPs has the potential for decreasing infection rates of implanted devices. These findings have important consequences to the patient management component of our current health care technology.
Highlights
INTRODUCTORY PARAGRAPH/ABSTRACT: Medical devices are an integral part of therapeutic management; despite their importance, they carry a significant risk of microbial infection
We report the bidirectional covalent coupling of an engineered cationic antimicrobial peptide, WLBU2, to various biological surfaces is accomplished
We have demonstrated that membrane perturbation is the major mechanism by which engineered cationic antimicrobial peptide (eCAP) function[11]
Summary
Watkins[3], Kazi Islam[2], Ronald C. INTRODUCTORY PARAGRAPH/ABSTRACT: Medical devices are an integral part of therapeutic management; despite their importance, they carry a significant risk of microbial infection. We report the bidirectional covalent coupling of an engineered cationic antimicrobial peptide (eCAP), WLBU2, to various biological surfaces is accomplished. WLBU2-conjugated surfaces are shown to retain potent antimicrobial activity related to bacterial surface adhesion. This study provides proof of principle that covalently coating laboratory and bone-regenerating materials with eCAPs has the potential for decreasing infection rates of implanted devices. These findings have important consequences to the patient management component of our current health care technology. Cationic antimicrobial peptides (CAPs) have been proposed as an alternative therapeutic for the management of microbial infection. Untapped source of therapeutics[2]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.